Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction

Journal of Clinical Oncology

Volumn 12, Issue 3, 1994, Pages 475-482

  Datta, Yvonne H ^a   Adams, Paul T ^a   Drobyski, William R ^a   Ethier, Stephen P ^a   Terry, Valeri H ^a   Roth, Mark S ^a  

^a C570D MSRB II ^*

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BLOOD ANALYSIS; BONE MARROW BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CYTAPHERESIS; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; OCCULT CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0028223380     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.3.475     Document Type: Article

References (36)

1. Diel IJ, Kaufmann M, Goerner R, et al: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 10:1534-1539, 1992
2. Mansi JL, Berger U, Easton D, et al: Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. Br Med J 295:1093-1096, 1987
3. Mansi JL, Easton D, Berger U, et al: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27:1552-1555, 1991
4. Sharp JP, Vaughn WP, Kessinger A, et al: Significance of detection of tumor cells in hematopoietic stem cell harvests of patients with breast cancer, in Dicke KA, Armitage JO, Dicke-Evinger MJ (eds): Autologous Bone Marrow Transplantation V. Omaha, NE, University of Nebraska Medical Center, 1990, pp 385-391
5. Frank JA, Ling A, Patronas NJ, et al: Detection of malignant bone tumors: MR imaging vs scintigraphy. Am J Roentgenol 155:1043-1048, 1990
6. Okuyama S, Ito Y, Awano T, et al: Bone tumor imaging by scintigraphy of the skeleton, marrow reticuloendothelial system, and the proliferative tissue. Am J Roentgenol Radium Ther Nucl Med 125:965-971, 1975
7. Leslie DS, Johnston WW, Daly L, et al: Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am J Clin Pathol 94:8-13, 1990
8. Osborne MP, Asina S, Wong GY, et al: Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: Sensitivity in a model system. Cancer Res 49:2510-2513, 1989
9. Debus E, Moll R, Franke WW, et al: Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Clin Pathol 114:121-129, 1984
10. Cote RJ, Rosen PP, Hakes TB, et al: Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12:333-340, 1988
11. Thor A, Viglione MJ, Ohuchi N, et al: Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow. Breast Cancer Res Treat 11:133-145, 1988
12. Sharp JG, Kessinger A, Vaughan WP, et al: Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int J Cell Cloning 10:92-97, 1992
13. Morecki S, Pavlotzky F, Margel S, et al: Purging breast cancer cells in preparation for autologous bone marrow transplantation. Bone Marrow Transplant 4:357-363, 1987
14. Shpall EJ, Bast RC Jr, Joines WT, et al: Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant 2:145-151, 1991
15. O'Briant KC, Shpall EJ, Houston LL, et al: Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide. monoclonal antibodies, and magnetic microspheres. Cancer 6:1272-1278, 1991
16. Joshi SS, Novak DJ, Messbarger L, et al: Levels of detection of tumor cells in human bone marrow with or without prior culture. Bone Marrow Transplant 6:179-183, 1990
17. Moll R, Franke WW, Schiller DL, et al: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24, 1982
18. Bartek J, Taylor-Papadimitriou J, Miller N, et al: Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int J Cancer 36:299-306, 1985
19. Roth MS, Antin JH, Bingham EL, et al: Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leuke-mia. Blood 74:882-885, 1989
20. Bader BL, Jahn L, Franke WW: Low level expression of cytokeratin 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 47:300-319, 1988
21. Savtchenko ES, Schiff TA, Jiang C-K, et al: Embryonic expression of the human 40-kD keratin: Evidence from a processed pseudogene sequence. Am J Hum Genet 43:630-637, 1988
22. Bartek J, Bartkova J, Schneider J, et al: Expression of monoclonal antibody-defined epitopes of keratin 19 in human tumours and cultured cells. Eur J Cancer Clin Oncol 22:1441-1452, 1993
23. Schlimok G, Funke I, Bock B, et al: Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8:831-837, 1990
24. Broers JLV, Ramaekers CS, Rot MK, et al: Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 48:3221-3229, 1988
25. Pujol J-L, Grenier J, Daures J-P, et al: Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53:61-66, 1993
26. Wood DP Jr, Banks ER, Humphries S, et al: Comparison of immunohistochemistry and polymerase chain reaction amplification of mRNA in the detection of prostate cancer micrometastases. Proc Am Assoc Cancer Res 34:190, 1993 (abstr 1135)
27. Delage R, Soiffer RJ, Dear K, et al: Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 78:2759-2767, 1991
28. Gribben JG, Freedman AS, Neuberg D, et al: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525-1533, 1991
29. Roth MS, Antin JH, Ash R, et al: Prognostic significance of Philadelphia chromosome positive cells detected by the polymerase chain reaction following allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 79:276-282, 1992
30. Osborne RJ, Merlo GR, Mitsudomi T, et al: Mutations in the p53 gene in primary human breast cancers. Cancer Res 51:6194-6198, 1991
31. Naito H, Kuzumaki N, Uchino J, et al: Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 6:762-765, 1991
32. Mattano LA Jr, Moss TJ, Emerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptasepolymerase chain reaction. Cancer Res 52:4701-4705, 1992
33. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
34. Chelly J, Concordet JP, Kaplan JC, et al: Illegitimate transcription: Transcription of any gene in any cell type. Proc Natl Acad Sci USA 86:2617-2621, 1989
35. Kaplan J-C, Kahn A, Chelly J: Illegitimate transcription: Its use in the study of inherited disease. Hum Mutat 1:357-360, 1992
36. Sarkar G, Sommer SS: Access to a messenger RNA sequence or its protein product is not limited by tissue of species specificity. Science 244:331-334, 1989